532 related articles for article (PubMed ID: 27810560)
1. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.
Sousa J; Alves G; Fortuna A; Falcão A
Pharm Res; 2017 Nov; 34(11):2260-2269. PubMed ID: 28748398
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
Tao T; Zhao Y; Yue P; Dong WX; Chen QH
Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
5. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy.
Carvalho FC; Campos ML; Peccinini RG; Gremião MP
Eur J Pharm Biopharm; 2013 May; 84(1):219-27. PubMed ID: 23207328
[TBL] [Abstract][Full Text] [Related]
6. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
Perez AP; Mundiña-Weilenmann C; Romero EL; Morilla MJ
Int J Nanomedicine; 2012; 7():1373-85. PubMed ID: 22457595
[TBL] [Abstract][Full Text] [Related]
7. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
9. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease.
Rao M; Agrawal DK; Shirsath C
Drug Dev Ind Pharm; 2017 Jan; 43(1):142-150. PubMed ID: 27533244
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Ved PM; Kim K
Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
Hu KL; Mei N; Feng L; Jiang XG
Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
[TBL] [Abstract][Full Text] [Related]
12. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
Kumar A; Garg T; Sarma GS; Rath G; Goyal AK
Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136
[TBL] [Abstract][Full Text] [Related]
13. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
Zhao Y; Yue P; Tao T; Chen QH
Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
[TBL] [Abstract][Full Text] [Related]
14. In situ gel-forming system: an attractive alternative for nasal drug delivery.
Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone.
Gu F; Ma W; Meng G; Wu C; Wang Y
Acta Pharm; 2016 Dec; 66(4):555-562. PubMed ID: 27749254
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of Brain Bioavailability Using Thermoreversible Cubosomal Formulation.
Jain H; Prabhakar B; Shende PK
Mol Pharm; 2024 May; 21(5):2534-2543. PubMed ID: 38547474
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
18. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
Chow HH; Anavy N; Villalobos A
J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
[TBL] [Abstract][Full Text] [Related]
19. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
20. Piribedil loaded thermo-responsive nasal in situ gelling system for enhanced delivery to the brain: formulation optimization, physical characterization, and in vitro and in vivo evaluation.
Uppuluri CT; Ravi PR; Dalvi AV; Shaikh SS; Kale SR
Drug Deliv Transl Res; 2021 Jun; 11(3):909-926. PubMed ID: 32514705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
